Is Innovation Pharmaceuticals Inc. (IPIX) a Buy, Sell, or Hold?
OTC : IPIX
Innovation Pharmaceuticals Inc. — News
$0.0025 USD
$0.0 (525.0%)
- Volume
- 682.15K
- Average Volume
- 179.19K
- Market Capitalization
- $1.3M
- P/E Ratio
- -0.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.05
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.03
- Current Ratio
- $0.33
| Source | Headline |
|---|---|
|
Innovation X Advisors Participates in Shield AI's $1.5 Billion Series G Financing
NEW YORK--(BUSINESS WIRE)--Today, late-stage venture capital firm Innovation X Advisors LLC (“Innovation X”) announced its participation in the $1.5 billion Series G financing of Shield AI, Inc. (“Shield AI”), a San Diego-based defense technology company specializing in artificial intelligence, autonomous systems, and next-generation aircraft. The financing values Shield AI at $12.7 billion post-money. Innovation X's participation reflects its investment thesis in companies operating at the int. businesswire.com - 2026-07-29 09:07:00 |
|
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts
Newly Constructed Phase 2 now 100% Leased Further Solidifies Innovation Park as Boston's Premier Advanced Manufacturing Destination BOSTON, June 22, 2026 /PRNewswire/ -- IQHQ, Inc. today announced that AdvanCell has signed a long-term ~128,000 square foot lease for the entire 1 Corporate Drive building at Innovation Park, IQHQ's premier life science and advanced manufacturing campus in Andover, Massachusetts. The transaction is one of the largest life science leases in Greater Boston this year and brings the newly constructed Phase 2 of Innovation Park to 100% leased. prnewswire.com - 2026-06-22 08:00:00 |
